Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts

BACKGROUND: Cyclophosphamide treatment on a six-day repeating metronomic schedule induces a dramatic, innate immune cell-dependent regression of implanted gliomas. However, little is known about the underlying mechanisms whereby metronomic cyclophosphamide induces innate immune cell mobilization and...

Descripción completa

Detalles Bibliográficos
Autores principales: Doloff, Joshua C, Waxman, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523019/
https://www.ncbi.nlm.nih.gov/pubmed/25952672
http://dx.doi.org/10.1186/s12885-015-1358-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523019/
https://www.ncbi.nlm.nih.gov/pubmed/25952672
http://dx.doi.org/10.1186/s12885-015-1358-y

Ejemplares similares